Kanda, Yoshinobu http://orcid.org/0000-0002-4866-9307
Usuki, Kensuke
Inagaki, Mitsuhiro
Ohta, Akiko
Ogasawara, Yoji
Obara, Naoshi
Kako, Shinichi
Kurokawa, Mineo
Shimada, Naoki
Suzuki, Takahiro
Hama, Asahito
Yamaguchi, Hiroki
Nakao, Shinji
Yamazaki, Hirohito
Funding for this research was provided by:
Ministry of Health, Labor and Welfare of Japan (20FC1018)
Article History
Received: 26 November 2022
Revised: 27 December 2022
Accepted: 27 December 2022
First Online: 3 January 2023
Conflict of interest
: Y.K. received research support from Kyowa Kirin, Chugai Pharmaceutical, and Shionogi, and received honoraria from Sanofi, Novartis Pharma, Kyowa Kirin, Chugai Pharmaceutical, and Shionogi. K.U. received research funding from Novartis Pharma, Chugai, Astellas, and Kyowa Kirin, speaker bureaus for Novartis Pharma, Astellas, Kyowa Kirin, Sanofi, and Chugai, and consulting bureaus for Chugai, Sanofi, Kyowa Kirin, and Astellas, and Alnylam Japan. M.I. received honoraria from Sanofi, Novartis Pharma, and Kyowa Kirin. S.K. received honoraria from Sanofi, Novartis Pharma, Kyowa Kirin, and Chugai Pharmaceutical. M.K. received research funding from Astellas Pharma, Kyowa Kirin, Chugai Pharmaceutical, and Shionogi and received honoraria from Sanofi, Kyowa Kirin, Chugai Pharmaceutical, and Astellas Pharma. T.S. received honoraria from Sanofi, Novartis Pharma, Kyowa Kirin, and Chugai Pharmaceutical. H.Y. received research funding from Astellas Pharma, and received honoraria from Novartis Pharma, Kyowa Kirin, and Chugai Pharmaceutical. S.N. received honoraria from Sanofi, Novartis Pharma, Kyowa Kirin, and Chugai Pharmaceutical. H.Y. received honoraria from Novartis Pharma and Kyowa Kirin.